sodium(2S,3S,4R,5R,6R)-6-(((2R,3R,4R,5R,6R)-6-(((2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-(((2R,3S,4R)-4-hydroxy-5-(sulfonatoamino)-2-((sulfonatooxy)methyl)-3,4-dihydro-2H-pyran-3-yl)oxy)-5-(sulfonatooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfonatoamino)-4-(sulfonatooxy)-2-((sulfonatooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-((sulfonatooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylate
Fondaparinux Sodium Impurity 2 is a fully characterized chemical compound used as a reference standard of API Fondaparinux. The standard offered is compliant with regulatory guidelines. Fondaparinux Sodium Impurity 2 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
